FDA inspection
Sun Pharma Canada Inc.: FDA inspection ending Mar 27, 2026
FDA inspection 1312804 · No Action Indicated (NAI) · Brampton
Key facts
| Inspection ID | 1312804 |
|---|---|
| Firm | Sun Pharma Canada Inc. |
| FEI number | 3002808384 |
| Address | 130 East Dr |
| City | Brampton |
| Country | Canada |
| Fiscal year | 2026 |
| Inspection end date | Mar 27, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data